Progrès récents dans les thérapies ciblées dans le traitement du cancer du sein métastatique HER2-positif
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference39 articles.
1. The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of Herceptin (trastuzumab) therapy for breast cancer;Pegram;Cancer Treat Res,2000
2. HER-2/neu (c-erb-B2) gene and protein in breast cancer;Ross;Am J Clin Pathol,1999
3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
4. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
5. The distinctive nature of HER2-positive breast cancers;Burstein;N Engl J Med,2005
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Photothermal Depth Profiling of Gelatin-Stabilised Gold Nanorods-Trastuzumab Conjugate as a Potential Breast Cancer Photothermal Agent;Journal of Inorganic and Organometallic Polymers and Materials;2024-07-03
2. Trastuzumab conjugated porphyrin-superparamagnetic iron oxide nanoparticle: A potential PTT-MRI bimodal agent for herceptin positive breast cancer;Photodiagnosis and Photodynamic Therapy;2020-09
3. Management of breast cancer during COVID‐19 pandemic in Morocco;The Breast Journal;2020-05-30
4. Données en vie réelle de l’utilisation du trastuzumab IV dans le carcinome mammaire métastatique HER2-positif;Oncologie;2017-07
5. Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer;Scientific Reports;2017-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3